Access denied

You are not authorized to access this page.
Project Sponsor Location(s) Topics Start End
Resynchronization Hemodynamic Treatment for Heart Failure Management Study (Rythm ICD) United States Cardiovascular Disease
Safety of Sports for Patients with Implantable Cardioverter-Defibrillators: A Multicenter Registrry Yale University United States Cardiovascular Disease
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System (CF-EAS) for the Treatment of Symptomatic Atrial Fibrillation (ENABLE-AF) United States Cardiovascular Disease
Pacemarker & Beta-Blocker Therapy Post-Myocardial Infarct Northwestern University United States Cardiovascular Disease
Replace Registry United States Cardiovascular Disease
Body Surfacing Mapping to Guide Resynchronization Therapy for Congestive Heart Failure United States Cardiovascular Disease
St. Jude EP Fellowship Program United States Cardiovascular Disease
An observational study assessing the management of gastrointestinal and urogenital bleeding events in patients with atrial fibrillation treated with dabigatran etexilate (PRADAXA) Boehringer Ingleheim United States Cardiovascular Disease
ZERO AF Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation Boston Scientific Corporation United States Cardiovascular Disease
Medtronic - 2015 EP Fellowship 20141212 RB United States Cardiovascular Disease, Residencies, Fellowships, and Postdoctoral Training
St Jude Medical - 2015 Electrophysiology Fellowship 20150226 United States Cardiovascular Disease, Residencies, Fellowships, and Postdoctoral Training
ENSURE in AF: Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Parallel Group Study Comparing Edoxaban with Enoxaparin/Warfarin Followed by Warfarin Alone in Subjects Undergoing Planned electrical cardioversion of nonvalvular atrial fibrillat Czech Republic Cardiovascular Disease